◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › LYB

LyondellBasell Industries NV (LYB) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

BASIC MATERIALS · Specialty Chemicals · DATA UPDATED 2026-07-18

LyondellBasell Industries NV (LYB) operates in the Specialty Chemicals industry and is headquartered in Rotterdam, Netherlands with about 18,970 employees. Its market capitalization is roughly $19 billion. In the fiscal year ended 2025-12-31, LYB reported $30.2B in revenue and ($743M) in net income.

LyondellBasell Industries N.V. operates as a chemical company in the United States, Germany, China, Mexico, Italy, Japan, France, Poland, the Netherlands, and internationally.

Interactive charts & full statements → Open the LYB valuation workbench →

LYB Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Total Revenue$29.7B$30.2B$40.3B$41.1B$50.5B$46.2B$27.8B$34.7B$39.0B$34.5B$29.2B$32.7B$45.6B$44.1B$45.4B$48.2B$41.2B$30.8B$50.7B$17.1B
Gross Profit$2.9B$2.7B$4.6B$5.3B$6.6B$8.8B$3.4B$5.4B$6.5B$6.4B$6.0B$7.1B$6.7B$6.1B$5.8B$5.5B$4.0B$1.5B$1.9B$1.9B
Gross Margin %9.7%9.0%11.3%12.8%13.1%19.0%12.2%15.6%16.6%18.6%20.5%21.5%14.6%13.9%12.7%11.3%9.8%4.7%3.8%11.2%
Operating Income (EBIT)($202M)($327M)$1.8B$3.1B$5.1B$6.8B$1.6B$4.1B$5.2B$5.5B$5.1B$6.1B$5.7B$5.1B$4.7B$4.3B$2.9B$317M($5.9B)$934M
Operating Margin %-0.7%-1.1%4.5%7.4%10.1%14.7%5.6%11.8%13.4%15.8%17.3%18.7%12.6%11.6%10.3%9.0%7.1%1.0%-11.7%5.5%
Net Income($793M)($743M)$1.4B$2.1B$3.9B$5.6B$1.4B$3.4B$4.7B$4.9B$3.8B$4.5B$4.2B$3.9B$2.8B$2.1B$10.2B($2.9B)($7.3B)$661M
Net Margin %-2.7%-2.5%3.4%5.1%7.7%12.2%5.1%9.8%12.0%14.1%13.1%13.7%9.2%8.8%6.3%4.5%24.7%-9.3%-14.4%3.9%
EBITDA$1.3B$1.2B$3.6B$4.6B$6.3B$8.7B$3.3B$5.7B$6.9B$7.2B$6.6B$7.6B$7.1B$6.3B$5.8B$5.5B$11.4B($714M)($3.8B)$1.8B
Earnings Per Share (EPS)$-2.43$-2.31$4.17$6.48$11.84$16.80$4.25$9.60$12.05$12.23$9.13$9.61$8.01$6.77$4.94$3.75$17.93$-5.08$-12.98$1.17
Shares Outstanding (M)323M322M326M326M328M334M334M353M389M399M420M466M521M570M577M572M566M564M564M564M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

LYB Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue$7.2B$7.1B$7.7B$7.7B$7.7B$9.5B$8.6B$8.7B
Gross Profit$701M$460M$906M$800M$549M$750M$1.3B$1.4B
Gross Margin %9.7%6.5%11.7%10.4%7.1%7.9%15.1%16.5%
Operating Income (EBIT)$239M($40M)($731M)$330M$114M($659M)$865M$999M
Operating Margin %3.3%-0.6%-9.5%4.3%1.5%-6.9%10.1%11.5%
Net Income$125M($140M)($892M)$114M$175M($598M)$570M$923M
Net Margin %1.7%-2.0%-11.5%1.5%2.3%-6.3%6.6%10.6%
EBITDA$617M$345M($368M)$719M$489M($373M)$1.3B$1.7B
Earnings Per Share (EPS)$0.39$-0.43$-2.74$0.35$0.54$-1.83$1.75$2.83
Shares Outstanding (M)323M322M326M322M324M326M326M326M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

LYB Free Cash Flow History

Cash flowTTM → 2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Cash from Operations (CFO)$2.6B$2.3B$3.8B$4.9B$6.1B$7.7B$3.4B$5.0B$5.5B$5.2B$5.6B$5.8B$6.0B$4.8B$4.8B$2.9B$2.0B($787M)$1.1B$1.2B
Capital Expenditures (CapEx)$2.6B$1.9B$1.8B$1.5B$1.9B$2.0B$1.9B$2.7B$2.1B$1.5B$2.2B$1.4B$1.5B$1.6B$1.1B$1.1B$692M$779M$1.0B$411M
Free Cash Flow (FCF)($70M)$384M$2.0B$3.4B$4.2B$5.7B$1.5B$2.3B$3.4B$3.7B$3.4B$4.4B$4.5B$3.3B$3.7B$1.8B$1.3B($1.6B)$90M$769M
FCF Margin %-0.2%1.3%4.9%8.3%8.4%12.4%5.2%6.5%8.6%10.6%11.5%13.5%10.0%7.4%8.2%3.8%3.2%-5.1%0.2%4.5%
Dividends Paid$2.4B$1.8B$1.7B$1.6B$3.2B$1.5B$1.4B$1.5B$1.6B$1.4B$1.4B$1.4B$1.4B$1.1B$2.4B$2.9B$522M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

LYB Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Cash from Operations (CFO)($269M)$1.5B$983M$351M($579M)$1.9B$670M$1.3B
Capital Expenditures (CapEx)$269M$1.4B$406M$539M$483M$504M$368M$484M
Free Cash Flow (FCF)($538M)$79M$577M($188M)($1.1B)$1.4B$302M$864M
FCF Margin %-7.5%1.1%7.5%-2.5%-13.8%14.9%3.5%10.0%
Dividends Paid$224M$1.3B$443M$445M$433M$437M$437M$438M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

LYB Balance Sheet History

Balance sheet2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
Total Assets$34.0B$34.0B$35.7B$37.0B$36.4B$36.7B$35.4B$30.4B$28.3B$26.2B$23.4B$22.8B$24.2B$27.3B$24.2B$22.8B$25.5B$27.8B$28.7B
Cash & Cash Equivalents$2.6B$3.4B$3.4B$3.4B$2.2B$1.5B$1.8B$858M$332M$1.5B$875M$924M$1.0B$4.5B$2.7B$1.1B$4.2B$558M$858M
Total Liabilities$23.8B$23.8B$23.2B$23.9B$23.6B$24.8B$27.3B$22.3B$17.9B$17.3B$17.4B$16.2B$15.9B$14.8B$13.0B$12.2B$13.9B$36.6B$34.6B
Total Debt (Short + Long-Term)$12.9B$13.3B$11.5B$11.6B$11.7B$11.9B$16.3B$12.3B$9.4B$8.6B$9.0B$8.0B$7.1B$5.8B$4.4B$4.0B$6.1B$7.0B$24.0B
Total Shareholders' Equity$10.0B$10.1B$12.5B$12.9B$12.6B$11.9B$8.0B$8.0B$10.3B$8.9B$6.0B$6.5B$8.3B$12.5B$11.1B$10.6B$11.5B($9.0B)($6.1B)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LYB viewer.

Other Companies in Specialty Chemicals

← LXUAll stocksLYEL →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.